**Sharps Technology Holds Annual Meeting, Approves Key Resolutions**
**Melville, NY – December 23, 2024** – Sharps Technology, Inc. (NASDAQ: STSS), a medical device company specializing in innovative syringe solutions, announced the results of its Annual Meeting of Stockholders, where several key proposals were approved.
### **Board Elections and Auditor Ratification**
Shareholders elected six directors to the company's Board, including **Soren Bo Christiansen, Paul K. Danner, Timothy J. Ruemler, Brenda Baird Simpson, Jason Monroe, and Robert M. Hayes**. Each director will serve until their successors are elected or until earlier resignation or removal.
In addition, shareholders ratified the appointment of **PKF O’Connor Davies LLP** as the company’s independent auditor for fiscal year 2024. The proposal received overwhelming support, with **942,555 votes in favor**, **12,402 against**, and **5,898 abstentions**.
### **Approval of 2024 Equity Incentive Plan**
The company’s **2024 Equity Incentive Plan**, aimed at attracting and retaining top talent, was also approved by stockholders. The measure passed with **613,501 votes in favor**, **37,979 against**, and **2,381 abstentions**.
### **Reverse Stock Split Update**
Sharps Technology confirmed it successfully implemented a **reverse stock split** on **October 16, 2024**. Fractional shares resulting from the split will be addressed individually for each participant.
### **Stock Performance**
Sharps Technology’s **common stock (STSS)** and **common stock purchase warrants (STSSW)** trade on the NASDAQ Capital Market.
### **Leadership Comments**
The company emphasized its commitment to corporate governance and growth through these initiatives. The resolutions are expected to strengthen Sharps Technology’s ability to execute its long-term strategy.
The Annual Meeting reflects Sharps Technology's focus on transparency, shareholder value, and operational excellence.